ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults

PHASE3CompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Alcoholism

Interventions

DRUG

Medisorb naltrexone 380 mg

Administered via intramuscular (IM) injection once every 4 weeks for up to 3.5 years.

DRUG

Medisorb naltrexone 190 mg

Administered via IM injection once every 4 weeks for up to 3.5 years.